ArticleClinical journal of gastroenterology2017
Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.
Koichiro Haruki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.